Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heme crystallization is a critical detoxification process in the malaria parasite Plasmodium falciparum, occurring within its acidic digestive vacuole (Coronado et al., 2014, Toxins). During the intraerythrocytic stage, the parasite catabolizes host hemoglobin to obtain essential amino acids, a process that releases large amounts of ferriprotoporphyrin IX (free heme), which is highly toxic to the parasite (Sullivan, 2002, Int J Parasitol). To survive, the parasite polymerizes this free heme into an insoluble, chemically inert crystalline form known as hemozoin, or malaria pigment (Egan, 2008, J Inorg Biochem). This crystallization process is the primary target for several classes of antimalarial drugs, most notably the quinolines such as chloroquine and quinine. These drugs interfere with the formation of hemozoin by binding to heme or the crystal growth face, leading to the accumulation of toxic free heme and subsequent parasite death (Huy et al., 2002, J Biol Chem). Despite its historical success as a target, the emergence of resistance—primarily through mutations in the Plasmodium falciparum chloroquine resistance transporter (PfCRT)—remains a significant challenge in malaria treatment.
Inhibition of the biocrystallization of toxic ferriprotoporphyrin IX into non-toxic hemozoin crystals within the parasite food vacuole (Sullivan, 2002, Int J Parasitol).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme crystallization (Plasmodium falciparum) (None).